What is the typical timeframe for the onset of hair loss after a Covid-19 (Coronavirus disease 2019) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hair Loss After COVID-19 Infection: Onset Timeline

Hair loss typically begins approximately 2-3 months after COVID-19 infection, with studies showing an average onset of about 50-74 days after initial COVID-19 symptoms. 1, 2

Timing and Characteristics of Post-COVID Hair Loss

  • Post-COVID hair loss most commonly presents as telogen effluvium (TE), a non-scarring diffuse hair loss that occurs following a stressful event such as infection 2
  • The mean duration from COVID-19 symptom onset to the appearance of hair loss is approximately 74 days, which is earlier than classic acute telogen effluvium 2
  • More specifically, one study found that hair shedding began on average 50 days after the first symptom of COVID-19 infection 1
  • This timeline is consistent with the Nature Reviews Microbiology guideline which notes that hair loss is more common at 1 year than at 2 months after infection, indicating its delayed onset 3

Risk Factors and Associations

  • Female gender is significantly associated with higher incidence of post-COVID hair loss (42.3% of women vs. 6.2% of men in one study) 4
  • Patients with hypertension showed higher rates of COVID-induced telogen effluvium (40.4% vs. 23.1% in those without hypertension) 4
  • Respiratory symptoms during COVID-19 infection are associated with higher rates of subsequent hair loss (31.7% vs. 14.0% in those without respiratory symptoms) 4
  • High temperature during COVID-19 infection is significantly associated with subsequent hair loss 5
  • Prior history of hair loss before COVID-19 infection increases the risk of developing post-COVID hair loss 5

Prevalence and Clinical Course

  • Studies show that approximately 27.9-36.7% of COVID-19 patients develop telogen effluvium after infection 4, 5
  • One large survey found that 52.7% of participants reported experiencing hair loss after COVID-19 infection 5
  • The severity of COVID-19 appears to correlate with the likelihood of developing hair loss, with hospitalized patients showing higher rates than outpatients (31.7% vs. 24.3%) 4
  • Most patients recover from post-COVID hair loss as it is typically self-limiting, though the timeline for recovery varies 2

Pathophysiology and Mechanisms

  • Post-COVID hair loss is believed to be primarily due to acute telogen effluvium, though other mechanisms may contribute including anagen effluvium, androgenetic alopecia, and alopecia areata 6
  • The physiological and psychological stress of COVID-19 infection likely triggers the hair follicles to prematurely enter the telogen (resting) phase 1
  • Medications used to treat COVID-19 (antibiotics, systemic corticosteroids, hydroxychloroquine) may also contribute to hair loss in some patients 1
  • The systemic inflammatory response during COVID-19 infection may disrupt normal hair cycle regulation 6

Clinical Implications and Management

  • Clinicians should consider a history of recent SARS-CoV-2 infection in patients presenting with diffuse hair loss 4
  • Trichoscopic findings typically include decreased hair density, empty follicles, and short regrowing hair 2
  • While most cases resolve spontaneously, topical minoxidil may provide relief from post-COVID hair loss, though more research is needed to confirm its efficacy 6
  • Hair loss after COVID-19 can significantly impact quality of life, with 8.6% of affected individuals reporting severe life impact according to the Dermatology Life Quality Index 5

Understanding the timeline and characteristics of post-COVID hair loss can help clinicians provide appropriate counseling and reassurance to affected patients, reducing unnecessary anxiety about this typically self-limiting condition.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.